The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has recommended key ...

The new study, published in the journal Brain and spearheaded by University of Cambridge scientist Dr Luca Peruzzotti-Jametti ...

Biochemist Svetlana Mojsov, honored for GLP-1 research that has transformed metabolic disease care, says she’s grateful to ...

The brain remains highly active during sleep, and mapping this activity can reveal early signs of neurological and sleep ...

A personalized neoantigen vaccine may be effective in patients with clear cell renal cell carcinoma, shared David A. Braun, ...

Cancer researchers have discovered something remarkable hiding in plain sight: a common bacteria used to make sauerkraut and ...

Pharvaris' innovative approach to treating hereditary angioedema (HAE) with deucrictibant. Read here for an investment ...

New biomarkers enhance multiple sclerosis (MS) diagnosis, enabling earlier detection and improved patient care, transforming MS management across the health care system.

Age-related macular degeneration (AMD) remains a leading cause of vision loss, but new therapies are reshaping its treatment.

Semaglutide has surged in popularity over the past two years, thanks to its remarkable effectiveness as a long-acting GLP-1 receptor agonist. High-profile endorsements, including from Elon Musk, have ...

Iovance Biotherapeutics, Inc. stock faces challenges with disappointing Q1 earnings and competition. Click for why potential ...